Literature DB >> 1902202

Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells.

C De Giovanni1, G Palmieri, G Nicoletti, L Landuzzi, K Scotlandi, A Bontadini, P L Tazzari, M Sensi, A Santoni, P Nanni.   

Abstract

The H-2b-negative B78HI clone (derived from B16 melanoma) was transfected with the H-2Kb gene; 4 cell clones expressing membrane H-2Kb antigens and 2 control clones (transfected with pSV2neo alone) were used for studies of metastatic ability, immunogenicity, NK sensitivity and homotypic adhesion. The experimental metastatic capacity of H-2Kb transfectants in syngenic mice was greatly diminished in comparison with control and parent cells. Both immune-mediated and intrinsic properties of transfectants correlated with their lower metastatic ability. A cell-mediated cytotoxic response was induced by repeated in vivo immunizations of syngeneic mice followed by in vitro restimulation of effectors when transfectants (but not controls) were used as immunizers and as targets. Moreover, homotypic adhesion of H-2Kb transfectants was significantly lower than that of controls. Sensitivity to NK cells of transfectants was not decreased in comparison to H-2-negative controls. It is known that in vitro treatment with IFN-gamma of H-2-positive B16 melanoma cells induces a simultaneous increase in H-2 expression and in experimental metastasis; treatment of H-2Kb transfectants with IFN-gamma induced a higher Kb expression, but no increase in metastatic ability, thus suggesting that the IFN-sensitive component that mediates enhancement of metastasis is not H-2Kb.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902202     DOI: 10.1002/ijc.2910480220

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.

Authors:  C Rozera; D Carlei; P L Lollini; C De Giovanni; P Musiani; E Di Carlo; F Belardelli; M Ferrantini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Inhibition of VLA-4 and up-regulation of TIMP-1 expression in B16BL6 melanoma cells transfected with MHC class I genes.

Authors:  F Xu; T Carlos; M Li; O Sanchez-Sweatman; R Khokha; E Gorelik
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

3.  Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.

Authors:  E Gorelik; M Kim; L Duty; T Henion; U Galili
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

4.  MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.

Authors:  T S Kim; E P Cohen
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

5.  Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.

Authors:  T VandenDriessche; M Bakkus; D Toussaint-Demylle; K Thielemans; H Verschueren; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

6.  Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.

Authors:  D Lauri; C De Giovanni; T Biondelli; E Lalli; L Landuzzi; A Facchini; G Nicoletti; P Nanni; E Dejana; P L Lollini
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

7.  Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.

Authors:  P Nanni; L Landuzzi; G Nicoletti; C De Giovanni; M Giovarelli; E Lalli; A Facchini; P L Lollini
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.